Blocknomi
TLDR AbbVie stock gained 1.17% to $266.27 after RINVOQ secured major EU approval. The approval covers adults and adolescents aged 12 and older with severe AA. Phase 3 studies showed…
Related articles
-
Core Scientific revenue doubles in Q2 as AI colocation expansion accelerates
Cointelegraph Published 28.07.2026 15:47
-
IMF Calls for Stricter Stablecoin Regulations in Brazil Amid Growing Crypto Market
Blocknomi Published 28.07.2026 11:46
-
Shiba Inu (SHIB) Targets Top 25: How 94.5% Whale Concentration Could Fuel Comeback
U.Today Published 22.07.2026 15:51
-
Google Gemini AI Reveals Shocking Solana Price Target for 2026
Cryptonews Published 17.07.2026 18:29
-
Microsoft (MSFT) Stock Poised for 6% Swing Following Wednesday’s Q4 Earnings
Blocknomi Published 28.07.2026 14:15
-
Token Terminal Supports Flying Tulip with Standardized On-Chain Metrics
BlockchainReporter Published 22.07.2026 09:00
-
Morning Minute: Bitcoin's New $15M Quantum Defense Fund
Decrypt Published 24.07.2026 12:29
-
Elon Musk Says SpaceX Engineering Data Will Train Grok’s Next Model
BeInCrypto Published 21.07.2026 09:32